PRLA PHARMA

Serial Number 86758012
606

Registration Progress

Application Filed
Sep 16, 2015
Under Examination
May 3, 2016
Approved for Publication
Mar 8, 2016
Published for Opposition
Mar 8, 2016
Registered

Trademark Image

PRLA PHARMA

Basic Information

Serial Number
86758012
Filing Date
September 16, 2015
Published for Opposition
March 8, 2016
Abandonment Date
December 10, 2018
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 10, 2018
Classes
005

Rights Holder

PrlA Pharma, Inc.

03
Address
1701 Stamford Lane
Austin, TX 78703

Ownership History

PrlA Pharma, Inc.

Original Applicant
03
Austin, TX

PrlA Pharma, Inc.

Owner at Publication
03
Austin, TX

Legal Representation

Attorney
Steven A. Fleckman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Dec 10, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 10, 2018 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 3, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 1, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
May 1, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 21, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 19, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 29, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 27, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 27, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 1, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 28, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 3, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 8, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 17, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 11, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 6, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 30, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 22, 2015 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 19, 2015 NWAP I NEW APPLICATION ENTERED Loading...
Sep 19, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the letter string "PrlA" in stylized font, with the letters "P" and "A" in upper case and the letters "r" and "l" in lower case, all appearing horizontally within a shaded oval, the letter "A" being separated from the letter "l" by a vertical dotted line extending from the top of the oval to the bottom of the oval, and all of the foregoing appearing above the word "PHARMA" in upper case in a different stylized font.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PRL" AND "PHARMA"